HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis
Yi‐Wen Huang(University of Pisa), Zhihong Yang(Indiana University – Purdue University Indianapolis)
Cited by 17
Related Papers
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Manganese and copper additions differently reduced cadmium uptake and accumulation in dwarf Polish wheat (Triticum polonicum L.)
|Journal of Hazardous Materials|2023|46